SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015821
Filing Date
2018-11-14
Accepted
2018-11-13 21:37:15
Documents
52
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 547463
2 ex31-1.htm EX-31.1 11784
3 ex31-2.htm EX-31.2 11878
4 ex32.htm EX-32.1 11573
  Complete submission text file 0001493152-18-015821.txt   2757503

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pcsa-20180930.xml EX-101.INS 355909
6 XBRL SCHEMA FILE pcsa-20180930.xsd EX-101.SCH 33504
7 XBRL CALCULATION FILE pcsa-20180930_cal.xml EX-101.CAL 42644
8 XBRL DEFINITION FILE pcsa-20180930_def.xml EX-101.DEF 121594
9 XBRL LABEL FILE pcsa-20180930_lab.xml EX-101.LAB 248916
10 XBRL PRESENTATION FILE pcsa-20180930_pre.xml EX-101.PRE 201377
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184948 | Film No.: 181180100
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1